Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis

Journal of Hepatology

Volumn 48, Issue 4, 2008, Pages 559-566

  Caraceni, Paolo ^a   Dazzani, Francesca ^a   Salizzoni, Eugenio ^b   Domenicali, Marco ^a   Zambruni, Andrea ^a   Trevisani, Franco ^a   Bernardi, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cirrhosis; Femoral artery blood flow; Muscle mass; Systemic hemodynamics

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEART INDEX; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; MALE; MUSCLE ATROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION;

ADULT; AGED; BLOOD FLOW VELOCITY; ELECTRIC IMPEDANCE; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; SEVERITY OF ILLNESS INDEX; SYNDROME; THIGH; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASODILATION;

EID: 40049084044     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.12.016     Document Type: Article

References (46)

1. Kowalski H.J., and Abelman W.H. The cardiac output at rest in Laennec cirrhosis. J Clin Invest 32 (1953) 1025-1033
2. Murray J.F., Dawson A.M., and Sherlock S. Circulatory changes in chronic liver disease. Am J Med 24 (1958) 358-367
3. Iwakiri Y., and Groszmann R.J. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 43 (2006) S121-S131
4. Sharara A.I., and Rockey D.C. Gastroesophageal variceal hemorrhage. N Engl J Med 345 (2001) 669-681
5. Moreau R., and Lebrec D. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Hepatology 43 (2006) 385-394
6. Kontos H.A., Shapiro W., Mauck H.P., and Patterson Jr. J.L. General and regional circulatory alterations in cirrhosis of the liver. Am J Med 37 (1964) 526-535
7. Campillo B., Chabrier P.E., Pelle G., Sediame S., Atlan G., Fouet P., et al. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology 22 (1995) 1423-1429
8. Rodríguez-Pérez F., Isales C.M., and Groszmann R.J. Platelet cytosolic calcium, peripheral hemodynamics, and vasodilatory peptides in liver cirrhosis. Gastroenterology 105 (1993) 863-867
9. Albillos A., Rossi I., Cacho G., Martínez M.V., Millán I., Abreu L., et al. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am J Physiol 268 (1995) G459-G464
10. Albillos A., de la Hera A., González M., Moya J.L., Calleja J.L., Monserrat J., et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37 (2003) 208-217
11. Lunzer M., Newman S., and Sherlock S. Skeletal muscle blood flow and neurovascular reactivity in liver disease. Gut 14 (1973) 354-359
12. De Vusser P., Bounameaux H., Verhaeghe R., and De Groote J. Liver cirrhosis, ascites, and peripheral vascular resistance [letter]. Lancet 2 (1985) 1078
13. Fernandez-Seara J., Prieto J., Quiroga J., Zozaya J.M., Cobos M.A., Rodriguez-Eire J.L., et al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology 97 (1989) 1304-1312
14. Iwao T., Oho K., Sakai T., Tayama C., Sato M., Nakano R., et al. Splanchic and extrasplanchnic arterial hemodynamics in patients with cirrhosis. J Hepatol 27 (1997) 817-823
15. Maroto A., Ginès P., Arroyo V., Ginès A., Salò J., Clària J., et al. Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction. Hepatology 17 (1993) 788-793
16. Dinenno F.A., Jones P.P., Seals D.R., and Tanaka H. Limb blood flow and vascular conductance are reduced with age in healthy humans: relation to elevations in sympathetic nerve activity and declines in oxygen demand. Circulation 100 (1999) 164-170
17. Dinenno F.A., Tanaka H., Stauffer B.L., and Seals D.R. Reductions in basal limb blood flow and vascular conductance with human ageing: role for augmented α-adrenergic vasoconstriction. J Physiol 536 (2001) 977-983
18. Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care 6 (2003) 79-85
19. Salerno F., Gerbes A., Ginès P., Wong F., and Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56 (2007) 1310-1318
20. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., and Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-649
21. Dazzani F., Micati M., Caraceni P., Drago G.M., Domenicali M., Pacilli P., et al. Transthoracic electrical bioimpedance: a non-invasive technique for the evaluation of the hemodynamic alterations in patients with liver cirrhosis. Digest Liver Dis 37 (2005) 786-792
22. Sramek B.B. Cardiac output by electrical impedance. Med Electron 13 (1982) 93-97
23. Du Bois D., and Du Bois E.F. A formula to estimate the approximate surface area if height and weight be known. Nutrition 5 (1989) 303-311
24. Bernardi M., Li Bassi S., Arienti V., De Collibus C., Scialpi C., Boriani L., et al. Systemic and regional hemodynamics in pre-ascitic cirrhosis: effects of posture. J Hepatol 39 (2003) 502-508
25. Chauveau M., Levy B., Dessanges J.F., Savin E., Bailliart O., and Martineaud J.P. Quantitative Doppler blood flow measurement method and in vivo calibration. Cardiovasc Res 19 (1985) 700-706
26. Sramek B.B. Thoracic electrical bioimpedance measurement of cardiac output. Crit Care Med 22 (1994) 1337-1339
27. Fuller H.D. The validity of cardiac output measurement by thoracic impedance: a meta analysis. Clin Invest Med 15 (1992) 103-112
28. Raaijmakers E., Faes T.J., Scholten R.J., Goovaerts H.G., and Heethaar R.M. A meta-analysis of three decades of validating thoracic impedance cardiography. Crit Care Med 27 (1999) 1203-1213
29. Schrier R.W., Arroyo V., Bernardi M., Epstein M., Henriksen J.H., and Rodés J. Peripheral vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8 (1988) 1151-1157
30. Holland C.K., Brown J.M., Scoutt L.M., and Taylor K.J. Lower extremity volumetric arterial blood flow in normal subjects. Ultrasound Med Biol 24 (1998) 1079-1086
31. MacDonald M.J., Shoemaker J.K., Tschakovsky M.E., and Hughson R.L. Alveolar oxygen uptake and femoral artery blood flow dynamics in upright and supine leg exercise in humans. J Appl Physiol 85 (1998) 1622-1628
32. Taylor K.J., and Holland S. Doppler US. Part I. Basic principles, instrumentation, and pitfalls. Radiology 174 (1990) 297-307
33. La Villa G., Barletta G., Righi D., Foschi M., Del Bene R., Tarquini R., et al. Vascular reserve in the lower limbs of cirrhotic patients: a duplex Doppler ultrasound study. Dig Liver Dis 34 (2002) 717-722
34. Guglielmi F.W., Panella C., Buda A., Budillon G., Caregaro L., Clerici C., et al. Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the "Nutritional Problems in Gastroenterology" Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 37 (2005) 681-688
35. Donato A.J., Uberoi A., Wray D.W., Nishiyama S., Lawrenson L., and Richardson R.S. Differential effects of aging on limb blood flow in humans. Am J Physiol Heart Circ Physiol 290 (2006) H272-H278
36. Uremović M., Pasić M.B., Serić V., Solter V.V., Budić R., Bosnjak B., et al. Ultrasound measurement of the volume of musculus quadriceps after knee joint injury. Coll Antropol 28 (2004) 227-233
37. Foley J.M., Jayaraman R.C., Prior B.M., Pivarnik J.M., and Meyer R.A. MR measurements of muscle damage and adaptation after eccentric exercise. J Appl Physiol 87 (1999) 2311-2318
38. Lund H., Christensen L., Savnik A., Boesen J., Danneskiold-Samsøe B., and Bliddal H. Volume estimation of extensor muscles of the lower leg based on MR imaging. Eur Radiol 12 (2002) 2982-2987
39. Takahashi H., Kuno S., Miyamoto T., Yoshioka H., Inaki M., Akima H., et al. Changes in magnetic resonance images in human skeletal muscle after eccentric exercise. Eur J Appl Physiol 69 (2004) 408-413
40. Radegran G., Blomstrand E., and Saltin B. Peak muscle perfusion and oxygen uptake in humans: importance of precise estimates of muscle mass. J Appl Physiol 87 (1999) 2375-2380
41. Fernàndez-Muñoz D., Caramelo C., Santos J.C., Blanchart A., Hernando L., and Lòpez-Novoa J.M. Systemic and splanchnic hemodynamic disturbances in conscious rats with experimental liver cirrhosis without ascites. Am J Physiol 249 (1985) G316-G320
42. Vorobioff J., Bredfeldt J.E., and Groszmann R.J. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 87 (1984) 1120-1126
43. Pizcueta P., Piqué J.M., Fernàndez M., Bosch J., Rodés J., Whittle B.J., et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 103 (1992) 1909-1915
44. Sato S., Ohnishi K., Sugita S., and Okuda K. Splenic artery and superior mesenteric artery blood flow: nonsurgical Doppler US measurement in healthy subjects and patients with chronic liver disease. Radiology 164 (1987) 347-352
45. Angeli P., Volpin R., Gerunda G., Craighero R., Roner P., Merenda R., et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29 (1999) 1690-1697
46. Duvoux C., Zanditenas D., Hézode C., Chauvat A., Monin J.L., Roudot-Thoraval F., et al. Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology 36 (2002) 374-380